Latest Blog Posts
Drug-Induced Pneumonitis
By Leah Margolis Fingerman, NP, Interstitial Lung Disease Committee Drug-induced pneumonitis refers to inflammation of the lung parenchyma caused by a medication. […]
New Critical Care Committee Co-Chairs
We are pleased to announce the new Critical Care Committee Co-Chairs, Molly Verderame and Vinny DeRienzo. Molly Verderame Molly Verderame is a […]
From CHEST: APP Intersection, “Optimizing lung transplant care: The expanding role of advanced practice providers”
This month, we are highlighting an article from The American College of Chest Physicians (CHEST)’s APP Intersection written by our Transplant Committee […]
“New Sepsis Guidelines Released!” from PulmCCM
Substack – PulmCCM The following preview and article are from PulmCCM, “an information service for critical care professionals.” You can register on […]
Announcing 2026 APAPP Awards
We are excited to announce that for the first time ever, we are giving awards at the National APAPP Conference in Las […]
Meet Your New COPD Committee Chairs
Meet Your New COPD Committee Chairs At the Association of Pulmonary Advanced Practice Providers (APAPP), we believe that the future of respiratory […]
The Changing Antifibrotic Landscape for the APP
The Changing Antifibrotic Landscape for the APP Kelsey Cramer DNP Antifibrotic therapy for Interstitial lung disease is shifting from a narrow, IPF- […]
3 APAPP Opportunities
As we push further into 2026, our mission to advance pulmonary medicine through collaboration and leadership has never been more vital. Whether […]